RESEARCH PHARMACEUTICAL SERVICES, INC. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 24, 2010

Attached files

file filename
10-K - FORM 10-K - RESEARCH PHARMACEUTICAL SERVICES, INC.c97814e10vk.htm
EX-31.2 - CFO CERTIFICATION PURSUANT TO SECTION 302 - RESEARCH PHARMACEUTICAL SERVICES, INC.c97814exv31w2.htm
EX-32.1 - CEO CERTIFICATION PURSUANT TO SECTION 906 - RESEARCH PHARMACEUTICAL SERVICES, INC.c97814exv32w1.htm
EX-21.1 - LIST OF SUBSIDIARIES - RESEARCH PHARMACEUTICAL SERVICES, INC.c97814exv21w1.htm
EX-31.1 - CEO CERTIFICATION PURSUANT TO SECTION 302 - RESEARCH PHARMACEUTICAL SERVICES, INC.c97814exv31w1.htm
EX-32.2 - CFO CERTIFICATION PURSUANT TO SECTION 906 - RESEARCH PHARMACEUTICAL SERVICES, INC.c97814exv32w2.htm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-151436) pertaining to the Research Pharmaceutical Services, Inc. 2007 Equity Incentive Plan of our report dated March 24, 2010, with respect to the consolidated financial statements of Research Pharmaceutical Services, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2009, filed with the Securities and Exchange Commission.
     
 
  /s/ Ernst & Young LLP
Philadelphia, PA
March 24, 2010

 

 

RESEARCH PHARMACEUTICAL SERVICES, INC. Reports